Navigation Links
CytomX to Present Overview of Precision Cancer Immunotherapies at the Jefferies Immuno-Oncology Summit
Date:4/13/2015

SOUTH SAN FRANCISCO, April 13, 2015 /PRNewswire/ -- CytomX, a biotechnology company developing Probody™ therapeutics for the treatment of cancer, today announced that Sean McCarthy, D. Phil., chief executive officer, will present at the upcoming Jefferies Immuno-Oncology Summit in Boston at 12:20 p.m. EDT on Wednesday, April 15. Dr. McCarthy will provide an overview of CytomX's Probody™ pipeline, including the company's precision cancer immunotherapy programs.

About CytomX Therapeutics
CytomX Therapeutics develops Probody™ therapeutics for the treatment of cancer. Probodies are masked antibodies that remain inert in healthy tissue but are activated specifically in the disease microenvironment. The Probody approach is designed to blunt systemic toxicities associated with antibodies and expand the therapeutic window of these drugs, unlocking new therapeutic targets. The Company is initially focusing this highly innovative platform to discover and develop new immunotherapy and antibody drug conjugate therapies to treat areas of major unmet medical need in oncology. CytomX has attracted multiple strategic collaborations with industry-leading pharmaceutical companies including Pfizer Inc., ImmunoGen and Bristol-Myers Squibb. CytomX is led by a seasoned and proven management team and is financed by leading life science investors, including Third Rock Ventures, Canaan Partners, Roche Venture Fund and Pfizer Venture Investments. For more information, please visit www.cytomx.com.

Media Contacts:
Canale Communications
Ian Stone
ian@canalecomm.com 
619-849-5388

 


'/>"/>
SOURCE CytomX Therapeutics
Copyright©2015 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. CytomX Appoints Immuno-Oncology Leader Rachel Humphrey, M.D., to Board of Directors
2. CytomX Expands Scientific and Clinical Advisory Boards with Leading Experts in Cancer Immunotherapy and Antibody Drug Conjugates
3. H3 Biomedicine to Present Early-Stage Cancer Research at the 2015 American Association of Cancer Research Annual Meeting
4. Delcath to present at Needham & Companys 14th Annual Healthcare Conference
5. BNC105 Biomarker Data to Be Presented at Asian Oncology Conference
6. Isis Pharmaceuticals to Present at Upcoming Investor Conferences
7. Omeros to Present at the 14th Annual Needham Healthcare Conference
8. Arena Pharmaceuticals to Present at the Annual Needham Healthcare Conference
9. Lexicon To Present At Needham & Companys 14th Annual Healthcare Conference
10. NW BIO TO PRESENT AT WORLD VACCINE CONGRESS 2015
11. OncoGenex Pharmaceuticals to Present at the 14th Annual Needham Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2019)... ... December 05, 2019 , ... ... and dialogue, today announces key issues to be discussed at its East/West ... Seasons Hotel in San Francisco. , Kicking off the week ...
(Date:12/4/2019)... ... December 04, 2019 , ... Tenex Health, Inc., a ... to treat chronic pain in soft and hard tissue, recently achieved a major ... , Dr. Bernard Morrey, Chief Medical Officer of Tenex Health, said, “Our ...
(Date:12/4/2019)... ... December 04, 2019 , ... ... announced the Top 17 Master's in Organizational Psychology Degree Programs for 2020. The ... universities in the nation. Each program is evaluated based on curriculum quality, graduation ...
Breaking Medicine Technology:
(Date:12/9/2019)... ... , ... Cocoa Beach is preparing to host its 10th annual “Surfing Santas” ... , What began as a simple family beach day a decade ago has grown ... years in, there’s no better place for Santa to loosen up as he gets ...
(Date:12/6/2019)... , ... December 06, 2019 , ... ... has been recognized for excellence in employee learning. The Omaha-based company has been ... organizations with the most successful employer-sponsored training and development programs worldwide. Rankings of ...
(Date:12/6/2019)... (PRWEB) , ... December 06, 2019 , ... Lasair Aesthetic Health Sponsors Toys for Tots ... Units of Botox to Patients Who Bring in Toys During the Holidays , Lasair Aesthetic ... From now until Christmas, patients who bring in a toy or toys worth more than ...
(Date:12/5/2019)... ... December 05, 2019 , ... ... resolution ultrasound (HRUS) technology to help their patients more easily detect ruptured silicone ... participating in this study and reporting on his experience. While the FDA currently ...
(Date:12/5/2019)... ... December 05, 2019 , ... ... patients met the hospital's newest staff member who will to help them take ... and affection during medical procedures.  , Rocket, presented by NutriSource® is a golden ...
Breaking Medicine News(10 mins):